RecruitingNot ApplicableNCT05836597

Functional Dyspepsia Treatment Using Virtual Reality

Effectiveness and Safety of Virtual Reality for the Treatment of Functional Dyspepsia

Sponsor

Mayo Clinic

Enrollment

30 participants

Start Date

Apr 1, 2024

Study Type

INTERVENTIONAL

Conditions

Functional Dyspepsia

Summary

The purpose of this study is to evaluate the effectiveness of using virtual reality to treat gastrointestinal symptoms related to functional dyspepsia.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria3

Symptoms of dyspepsia thought to represent functional dyspepsia, meeting Rome IV criteria
Had an upper endoscopy and assessment for Helicobacter pylori; if a patient is found to have H. pylori, treatment with confirmed eradication (by stool antigen test or urea breath test) will be required before the patient is eligible for study inclusion.
Patients will be considered for the study if they have undergone a complete history and physical examination during a previously scheduled consultation/evaluation visit with a gastroenterologist in the Mayo Clinic Florida General GI or Motility clinic.

Exclusion Criteria6

Symptoms are thought to represent an organic disorder (e.g., peptic ulcer disease, hepatitis, pancreatitis, inflammatory bowel disease, type I diabetes, a known malignancy, radiation-induced injury, an active infection, vasculitis, celiac disease), or patients have known uncontrolled GERD, esophagitis, eosinophilic esophagitis, or untreated H. pylori.
Patients with gastroparesis or cyclic vomiting syndrome.
Patients with prior surgery to the esophagus, stomach or duodenum.
Patients taking opioids.
Patients with motion sickness, vertigo, or a seizure disorder
IBS symptoms are not predominant.